Paco E. Bravo, MD

Cardiologist, Nuclear Medicine Physician, and Cardiovascular Imager at the University of Pennsylvania

[Paco E. Bravo, MD @pacoebravo]

@UGrewalMD @emirhanharbi23 @OncoThor @RonnyAllan1 @helops79 I don't think there are head-to-head studies, but based on what I've seen, Dotatate/dotanoc PET/CT are likely more sensitive to detect cardiac lesions. The thing is that it doesn't seem like having cardiac mets change the prognosis or management of these patients

[Paco E. Bravo, MD @pacoebravo]

@emirhanharbi23 @OncoThor @UGrewalMD @RonnyAllan1 @helops79 Sorry to interrupt your discussion, but we actually looked at this very question in the pub below:
Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT: Identification and Prognostic Significance | Journal of Nuclear Medicine

[FSR @StopSarcoidosis]

We are thrilled to announce Dr. Eliot Peyster, MD, MSc, from the University of Pennsylvania, as a recipient of the 2024 FSR Cardiac Sarcoidosis Grant

🔗 Learn more about FSR’s commitment to research: https://t.co/qGsEF0nttm

[FSR @StopSarcoidosis]

Advancing Awareness at AHA Scientific Sessions in Chicago! 🎉
📸: Dr. Selvaraj, our 2023 cardiac grantee, whose work is making a significant impact in the field of sarcoidosis research!
Together, we’re working to improve outcomes for those affected by sarcoidosis.

[CircImaging @CircImaging]

Measurement of point-of-care beta-hydroxybutyrate levels prior to FDG-PET is feasible and may facilitate the management of patients referred for myocardial inflammation @mkvidula @pacoebravo @PennCardiology @PennMedicine #AHAJournals @JiwonKimMD https://t.co/ksl4ZIpqUA

[Paco E. Bravo, MD @pacoebravo]

Love to see this, but the right answer should have been repeat the scan with longer ketosis, we're finally getting there

[ASNC Society @MyASNC]

49-year-old with frequent VEs underwent rest Rb-82 imaging and 24-hr. carbohydrate-restricted diet for F-18 FDG PET to exclude cardiac sarcoidosis. Beta-hydroxybutyrate level < 0.2 mmol/L (normal > 0.3 mmol/L). What is your interpretation? Vote below.

[Paco E. Bravo, MD @pacoebravo]

Reminds me of cards fellows looking at SPECT
https://t.co/Vn5HxZ9PQU

[JACC Journals @JACCJournals]

Stress perfusion battle royale! Through head to head comparison of stress perfusion #CMR vs 82Rb #cvPET after #YesCCT, both approaches had moderate sensitivities & high specificities to discriminate obstructive #cvCAD by #FFR. https://t.co/VfYboaIB29

#JACCIMG @lostrasmussen

[JACC Journals @JACCJournals]

Multicenter #JACCIMG #whyCMR study of #COVID19 pts w/ suspicion for cardiac involvement: nonischemic & ischemic patterns = frequent if cardiac symptoms, abnormal #ECG, or elevated cardiac biomarker elevation present. https://t.co/yYl8uBz6ps

#CardioTwitter @mkvidula

[Penn Heart & Vascular @PennCardiology]

A new @PennCardiology #clinicalcase aimed to:

👉formulate diagnoses of persistent FDG uptake on serial PET imaging

👉understand the mechanistic rationale of alt. causes that may result in persistent FDG uptake

https://t.co/ZJ8UQxe534

#Aneurysm #CVImaging @mkvidula @pacoebravo

[Paco E. Bravo, MD @pacoebravo]

Not always more is better, this study confirms that. Just image the chest in this population.

[Sarcoidosis_papers @sarcoid_papers]

Diagnostic yield of whole-body 18F-FDG PET/CT in patients with suspected cardiac sarcoidosis https://t.co/ShQXUEC53a

[Paco E. Bravo, MD @pacoebravo]

If you adjust for LGE, FDG is no longer predictive of adverse events in patients with suspected inflammatory cardiomyopathy (it seems)

[Kate Hanneman @KateHanneman]

Very happy to share our latest publication out today in @radiology_rsna, led by recent @imagingtoronto super-fellow @Mbwaitken 🔥👏

➡️ In a meta-analysis of 37 studies and 3489 patients, #whyCMR and #FDGPET were predictive of MACE in cardiac sarcoidosis
https://t.co/2NYJnXZf9h

[Penn Heart & Vascular @PennCardiology]

Myocardial injury in patients with #COVID19 & suspected cardiac involvement is not well understood.

This 📄 by @mkvidula et al. aimed to characterize myocardial injury in these patients referred for #CMR.

👉 https://t.co/GReZwd1a3f

#CardioTwitter

[Penn Radiology @PennRadiology]

Don't miss another Radiology Grand Round Session next week, on Tuesday, February 14 @ 12-1 PM! In person and live-streaming available. Stay tuned for more details. #radiology #grandrounds

[Myocarditis Fndn @myocarditisfndn]

The Myocarditis Foundation is Pleased to Announce the Recipient of the Foundation’s 2022 Fellowship Grant Award. Read about Dr. KC’s research here https://t.co/G8vfhdiUMw

[Penn Heart & Vascular @PennCardiology]

A new @pennmedicine study investigated the effect of immunosuppressive 🩺 therapy & biopsy 💉 status to achieve CTR, PTR or NR on myocardial FDG-PET/CT.

Learn more➡️ https://t.co/H5RollrTyg

@senthil_selv @mkvidula @leegoldbergmd8 @pacoebravo

[Paco E. Bravo, MD @pacoebravo]

@venkmurthy We discussed this

[Moath Said Alfawara,MD @m_alfawara]

Excited to share the latest work form #AlmallahLabs|@almallahmo on the utility of🧪Beta-hydroxybutyrate in Detecting 🫀Myocardial🍬Glucose Uptake Suppression in Patients Undergoing Inflammatory [18F]-FDG☢️PET Studies #cvNuc

🔗👉https://t.co/Fl4PIZylgJ

A 🧵 [1/7]
@WilliamZoghbi

[Paco E. Bravo, MD @pacoebravo]

@m_alfawara Nice study

[Paco E. Bravo, MD @pacoebravo]

@A_Khan_QRS @almallahmo @PanithayaC @venkmurthy @DorbalaSharmila Perfusion is helpful to aid establish the diagnosis, but I don't think is critical to assess treatment response on FDG

[Paco E. Bravo, MD @pacoebravo]

@DrRojulpoteC @SLUCards @KarthikG_MD @shivrajpatil Extremely happy for you Shay, congratulations, cards is a great career choice